메뉴 건너뛰기
Primary Care Companion to the Journal of Clinical Psychiatry
Volumn 14, Issue 5, 2012, Pages
Dextromethorphan and quinidine combination in emotional lability associated with depression: A case report
Author keywords

[No Author keywords available]
Indexed keywords

AMFEBUTAMONE; CHLORPROMAZINE; CITALOPRAM; CLONAZEPAM; DESVENLAFAXINE; DEXTROMETHORPHAN PLUS QUINIDINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LEVOTHYROXINE; MIRTAZAPINE; PAROXETINE; SELEGILINE; TOPIRAMATE; VENLAFAXINE;
EID: 84869382056     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.12l01400     Document Type: Letter
Times cited : (17)
References (5)
  • 1
    • 7044254695 scopus 로고    scopus 로고
    • Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: A randomized trial
    • AVP-923 ALS Study Group PubMed Show Abstract Show Abstract
    • Brooks BR, Thisted RA, Appel SH, et al; AVP-923 ALS Study Group. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004;63(8):1364-1370. PubMed Show Abstract Show Abstract
    • (2004) Neurology , vol.63 , Issue.8 , pp. 1364-1370
    • Brooks, B.R.1    Thisted, R.A.2    Appel, S.H.3
  • 2
    • 33646362026 scopus 로고    scopus 로고
    • Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis
    • Psuedobulbar Affect in Multiple Sclerosis Study Group PubMed doi:10.1002/ana.20828 Show Abstract Show Abstract
    • Panitch HS, Thisted RA, Smith RA, et al; Psuedobulbar Affect in Multiple Sclerosis Study Group. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol. 2006;59(5):780-787. PubMed doi:10.1002/ana.20828 Show Abstract Show Abstract
    • (2006) Ann Neurol , vol.59 , Issue.5 , pp. 780-787
    • Panitch, H.S.1    Thisted, R.A.2    Smith, R.A.3
  • 3
    • 33845217413 scopus 로고    scopus 로고
    • Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-label, dose-escalation study
    • PubMed doi:10.1016/j.clinthera.2006.10.005 Show Abstract Show Abstract
    • Thisted RA, Klaff L, Schwartz SL, et al. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study. Clin Ther. 2006;28(10):1607-1618. PubMed doi:10.1016/j.clinthera.2006.10.005 Show Abstract Show Abstract
    • (2006) Clin Ther , vol.28 , Issue.10 , pp. 1607-1618
    • Thisted, R.A.1    Klaff, L.2    Schwartz, S.L.3
  • 4
    • 45849139697 scopus 로고    scopus 로고
    • Dextromethorphan and quinidine combination for heroin detoxification
    • PubMed doi:10.1080/10550490802019543 Show Abstract Show Abstract
    • Akerele E, Bisaga A, Sullivan MA, et al. Dextromethorphan and quinidine combination for heroin detoxification. Am J Addict. 2008;17(3):176-180. PubMed doi:10.1080/10550490802019543 Show Abstract Show Abstract
    • (2008) Am J Addict , vol.17 , Issue.3 , pp. 176-180
    • Akerele, E.1    Bisaga, A.2    Sullivan, M.A.3
  • 5
    • 0030749566 scopus 로고    scopus 로고
    • A self report measure of affective lability
    • PubMed doi:10.1136/jnnp.63.1.89 Show Abstract Show Abstract
    • Moore SR, Gresham LS, Bromberg MB, et al. A self report measure of affective lability. J Neurol Neurosurg Psychiatry. 1997;63(1):89-93. PubMed doi:10.1136/jnnp.63.1.89 Show Abstract Show Abstract
    • (1997) J Neurol Neurosurg Psychiatry , vol.63 , Issue.1 , pp. 89-93
    • Moore, S.R.1    Gresham, L.S.2    Bromberg, M.B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.